Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-HALOPERIDOL | 1MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167174 |
TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167177 |
TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2022-08-18 | 2023-05-23 | 167179 |
TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2022-08-18 | 2022-09-08 | 167191 |
TEVA-ZOLMITRIPTAN | 2.5MG | TABLET | Resolved | 2022-08-18 | 2023-04-28 | 167200 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2022-08-18 | 2022-12-02 | 167203 |
TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2022-08-18 | 2023-04-28 | 167212 |
TEVA-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-08-18 | 2022-10-01 | 167215 |
NOVO-GESIC | 325MG | TABLET | Resolved | 2022-08-18 | 2022-09-23 | 167229 |
TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2022-08-18 | 2022-12-22 | 167237 |
TEVA-GLICLAZIDE | 80MG | TABLET | Resolved | 2022-08-18 | 2022-12-02 | 167244 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-08-18 | 2022-09-08 | 167246 |
TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2022-08-18 | 2022-12-15 | 167255 |
AVIANE 28 | 20MCG 100MCG | TABLET | Resolved | 2022-09-07 | 2022-12-02 | 168716 |
TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2022-09-07 | 2023-04-28 | 168726 |
TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2022-09-07 | 2022-10-01 | 168737 |
TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2022-09-07 | 2023-01-12 | 168741 |
TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2022-09-07 | 2022-12-22 | 168744 |
TEVA-SIMVASTATIN | 10MG | TABLET | Resolved | 2022-09-07 | 2023-06-21 | 168749 |
TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2022-09-22 | 2022-10-01 | 169948 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |